Page 105 - Read Online
P. 105
Yang et al. Mini-invasive Surg 2021;5:11 I http://dx.doi.org/10.20517/2574-1225.2021.06 Page 7 of 12
Figure 2. Glycemic control based on HbA1c for patients with T2DM. Patients were separated into four different HbA1c ranges (N = 87).
The increase in the number of patients under glycemic control (HbA1c < 6.0%) and the decrease in the number of patients with a high
HbA1c (≥ 7.0%) are shown. T2DM: Type 2 diabetes mellitus; HbA1c: glycosylated hemoglobin.
Figure 3. Medication use (anti-hyperglycemic agents) for patients with T2DM (N = 74). The decrease in insulin usage is shown. T2DM:
Type 2 diabetes mellitus.
